Wall Street analysts expect Abercrombie & Fitch (ANF) to post quarterly earnings of $2.15 per share in its upcoming report, which indicates a year-over-year decline of 14%. Revenues are expected to be $1.28 billion, up 5.5% from the year-ago quarter.The consensus EPS estimate for the quarter has been revised 2% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Before a company reveal ...

Core Insights - Spire Inc. (NYSE: SR) is a significant player in the energy sector, focusing on natural gas distribution [1][5] - Morgan Stanley has set a price target of $91 for Spire Inc., indicating a potential price increase of approximately 4.59% from its current price of $87 [1][5] - The company is preparing to host a conference call on November 14, 2025, to discuss its fiscal 2025 fourth quarter and year-end financial results, which may influence its stock price [3][5] Stock Performance - As of now, Spire Inc.'s stock is priced at $86.93, reflecting a slight increase of 0.06% or $0.055 today [2] - The stock has experienced a trading range between $86.52 and $87.21 for the day, with a yearly high of $87.64 and a low of $61.87, indicating volatility [2] Market Metrics - The company's market capitalization is approximately $5.13 billion, with a trading volume of 60,011 shares, suggesting moderate investor interest [4][5]

Company Overview - Vir Biotechnology, Inc. (VIR) shares increased by 6.9% to close at $6.05, supported by high trading volume, and have gained 8% over the past four weeks [1] - The rise in stock price is linked to positive investor sentiment regarding the company's late-stage pipeline candidate, tobevibart, aimed at treating chronic hepatitis delta [1] Financial Performance - The company is projected to report a quarterly loss of $0.70 per share, reflecting a year-over-year increase of 55.1% [2] - Expected revenues are $7.04 million, which is a significant increase of 195.6% compared to the same quarter last year [2] Earnings Estimates - The consensus EPS estimate for Vir Biotechnology has remained unchanged over the last 30 days, indicating stability in earnings expectations [3] - A stock's price typically does not continue to rise without trends in earnings estimate revisions, suggesting the need for monitoring future developments for VIR [3] Industry Context - Vir Biotechnology is categorized under the Zacks Medical - Biomedical and Genetics industry, which includes other companies like Tarsus Pharmaceuticals, Inc. (TARS) [4] - Tarsus Pharmaceuticals has seen a 1.9% increase in its stock price, closing at $69.75, with a notable return of 21.1% over the past month [4] Comparative Analysis - Tarsus Pharmaceuticals has a consensus EPS estimate of -$0.38, which is a 37.7% improvement from the previous year [5] - Tarsus currently holds a Zacks Rank of 4 (Sell), contrasting with Vir Biotechnology's Zacks Rank of 3 (Hold) [4][5]

Core Viewpoint - Kinsale Capital Group, Inc. (KNSL) has shown strong stock performance, with a recent increase of 5.4% to close at $466.26, following a period of decline, supported by solid trading volume and positive analyst ratings [1][2]. Group 1: Stock Performance - Kinsale Capital shares surged after Truist Securities reiterated its "Buy" rating and set a price target of $560, following positive meetings with management [2]. - The stock experienced a 3.7% loss over the past four weeks before the recent surge [1]. Group 2: Growth and Market Position - Kinsale Capital has strengthened its presence in the U.S. excess and surplus (E&S) market through consistent premium growth, healthy broker submissions, solid renewal activity, and disciplined underwriting [3]. - The company aims for long-term top-line growth of 10% to 20% [2]. Group 3: Financial Performance Expectations - Kinsale Capital is expected to report quarterly earnings of $4.66 per share, reflecting an 11% year-over-year increase, with revenues projected at $449.2 million, up 7.5% from the previous year [4]. - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in earnings expectations [6]. Group 4: Industry Context - Kinsale Capital Group is part of the Zacks Insurance - Property and Casualty industry, which includes other companies like Palomar (PLMR), which recently closed 3.8% higher [7].

Company Overview - Dave Inc. (DAVE) shares increased by 4.7% to close at $238.54, with notable trading volume exceeding typical levels [1] - The stock has gained 22.3% over the past four weeks, driven by a $125 million share repurchase program and an increase in 2025 revenue guidance to $505–$515 million [1] Earnings Expectations - The company is projected to report quarterly earnings of $2.09 per share, reflecting a year-over-year increase of 38.4% [2] - Expected revenues for the upcoming quarter are $131.17 million, which is a 41.8% increase compared to the same quarter last year [2] Stock Performance Insights - The consensus EPS estimate for DAVE has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without earnings estimate revisions [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting positive investor sentiment [4] Industry Comparison - DAVE is part of the Zacks Technology Services industry, where Kyndryl Holdings, Inc. (KD) has a Zacks Rank of 4 (Sell) and reported a 0.4% decrease in its last trading session [4][5] - Kyndryl's consensus EPS estimate has remained unchanged at $0.33, representing a significant year-over-year change of +3200% [5]

Core Viewpoint - Darden Restaurants (DRI) is expected to report quarterly earnings of $1.99 per share, reflecting a year-over-year increase of 13.7%, with revenues projected at $3.04 billion, up 10.2% from the previous year [1] Earnings Projections - The consensus EPS estimate has been revised downward by 0.3% in the last 30 days, indicating a reassessment by analysts [1][2] - Changes in earnings projections are crucial for predicting investor reactions and short-term stock price movements [2] Sales Estimates - Analysts estimate 'Sales- Olive Garden' to reach $1.31 billion, indicating a year-over-year change of +7.9% [3] - 'Sales- Other Business' is projected at $665.09 million, reflecting a year-over-year increase of +19.7% [4] - 'Sales- Fine Dining' is expected to be $290.21 million, showing a +4.1% change from the prior year [4] - 'Sales- LongHorn Steakhouse' is estimated at $783.54 million, indicating a +9.8% change from the previous year [4] Company-Owned Restaurants - Total company-owned restaurants are expected to reach 2,167, up from 2,040 a year ago [5] - Same-restaurant sales for LongHorn Steakhouse are projected to increase by 5.8%, compared to 3.7% in the previous year [5] - Company-owned restaurants for LongHorn Steakhouse are estimated at 594, up from 577 in the same quarter last year [5] - Olive Garden's company-owned restaurants are expected to be 936, compared to 923 a year ago [6] - Ruth's Chris Steak House is projected at 83, up from 82 last year [6] - Bahama Breeze is expected to have 28 company-owned restaurants, down from 44 in the previous year [6] - Seasons 52 is projected at 43, compared to 44 last year [7] - Eddie V's is expected to remain at 29, unchanged from the previous year [7] Stock Performance - Darden Restaurants shares have increased by +2.5% in the past month, slightly outperforming the +2.3% move of the Zacks S&P 500 composite [8] - The company holds a Zacks Rank 3 (Hold), indicating it is expected to mirror overall market performance in the near future [8]

Company Overview - Vimeo, Inc. (VMEO) shares increased by 60.9% to $7.74 in the last trading session, following a definitive agreement to be acquired by Bending Spoons for $1.4 billion [1] - The stock has shown a 25.9% gain over the past four weeks, indicating strong market interest [1] Earnings Expectations - Vimeo is expected to report quarterly earnings of $0.03 per share, reflecting a year-over-year decline of 40% [2] - Revenue projections stand at $106 million, which is a 1.4% increase compared to the same quarter last year [2] Earnings Estimate Revisions - The consensus EPS estimate for Vimeo has been revised 7.1% higher in the last 30 days, suggesting a positive trend that may lead to price appreciation [3] - Historical data indicates that trends in earnings estimate revisions are closely linked to near-term stock price movements [2][3] Industry Context - Vimeo holds a Zacks Rank of 1 (Strong Buy), indicating strong market confidence [4] - In the same technology services industry, Gen Digital (GEN) has a Zacks Rank of 4 (Sell) and has seen a 0.8% decline in the last trading session [4][5]

Core Insights - Emerson Electric (EMR) is expected to report quarterly earnings of $1.51 per share, reflecting a year-over-year increase of 5.6% [1] - Revenue projections stand at $4.58 billion, indicating a 4.6% increase from the previous year [1] - Analysts have revised the consensus EPS estimate 0.4% lower over the last 30 days, indicating a reevaluation of initial estimates [1][2] Revenue Estimates - Analysts project 'Net Sales- Intelligent Devices- Total' to reach $3.10 billion, a change of +3.5% year-over-year [3] - 'Net Sales- Software And Control- Total' is expected to be $1.49 billion, suggesting a +6.9% change year-over-year [4] - 'Net Sales- Intelligent Devices- Safety & Productivity' is estimated at $345.21 million, indicating a -1.7% change [4] - 'Net Sales- Intelligent Devices- Measurement & Analytical' is projected at $1.02 billion, reflecting a +4.3% change [4] - 'Net Sales- Intelligent Devices- Final Control' is expected to be $1.10 billion, a +5.5% change year-over-year [5] - 'Net Sales- Intelligent Devices- Discrete Automation' is estimated at $633.56 million, indicating a +2.5% change [5] - 'Net Sales- Software and Control- Test & Measurement' is projected at $369.82 million, reflecting a +4.2% change [6] - 'Revenue- Software And Control- Control Systems & Software' is expected to reach $1.11 billion, indicating a significant +59.2% change [6] EBIT Estimates - 'EBIT- Intelligent Devices- Total' is estimated at $757.44 million, compared to $693.00 million from the previous year [7] - 'EBIT- Intelligent Devices- Measurement & Analytical' is projected at $275.03 million, up from $252.00 million year-over-year [7] - 'EBIT- Intelligent Devices- Discrete Automation' is expected to reach $119.99 million, compared to $109.00 million in the same quarter last year [8] - 'EBIT- Software and Control- Total' is projected at $228.46 million, up from $129.00 million year-over-year [8] Stock Performance - Over the past month, shares of Emerson Electric have returned +4.1%, outperforming the Zacks S&P 500 composite's +2.3% change [9] - Currently, EMR holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [9]

Core Viewpoint - Group 1 Automotive (GPI) shares have shown significant growth, driven by strategic acquisitions and positive earnings expectations, indicating potential strength in the stock moving forward [1][2][3]. Group 1 Automotive (GPI) - GPI shares increased by 3.1% to close at $480.13, with a notable trading volume compared to typical sessions, and a total gain of 5.2% over the past four weeks [1]. - The company has focused on expanding its portfolio through acquisitions, including the Inchcape buyout in 2024, which is projected to add $2.7 billion in annualized revenues. Total acquired revenues for 2024 reached $3.9 billion, with $430 million in annualized revenues acquired year to date [2]. - The upcoming quarterly earnings report is expected to show earnings of $10.16 per share, reflecting a year-over-year increase of 3.7%, and revenues are anticipated to be $5.51 billion, up 17.3% from the previous year [3]. - The consensus EPS estimate for GPI has remained unchanged over the last 30 days, suggesting that the stock's price movement may not sustain without trends in earnings estimate revisions [4]. - GPI currently holds a Zacks Rank of 2 (Buy), indicating a favorable outlook compared to other stocks in the automotive retail and wholesale industry [5]. Industry Context - Group 1 Automotive is part of the Zacks Automotive - Retail and Wholesale industry, where AutoNation (AN) also operates. AN shares closed 0.7% higher at $214.83, with a return of 9.8% over the past month [5]. - AutoNation's consensus EPS estimate has increased by 0.7% over the past month to $4.62, representing a year-over-year change of 15.8% [6].

Group 1: Company Overview - WNS (Holdings) Limited shares increased by 14.3% to close at $74.7, driven by higher trading volume compared to typical sessions [1] - The stock has gained 9.4% over the past four weeks, reflecting investor optimism following Capgemini's announcement to acquire WNS for $76.50 per share in an all-cash deal [1] Group 2: Earnings Expectations - WNS is expected to report quarterly earnings of $0.95 per share, representing a year-over-year increase of 2.2% [2] - Revenue expectations for WNS stand at $323.35 million, which is a 3.5% increase from the same quarter last year [2] Group 3: Stock Performance and Estimates - The consensus EPS estimate for WNS has remained unchanged over the last 30 days, indicating that stock price movements may not continue without trends in earnings estimate revisions [3] - WNS currently holds a Zacks Rank of 3 (Hold), indicating a neutral outlook [4] Group 4: Industry Comparison - WNS is part of the Zacks Business - Services industry, where another company, Willdan Group (WLDN), saw a 1.3% increase to $73.26 and has returned 26.9% over the past month [4] - Willdan's consensus EPS estimate has also remained unchanged at $0.72, reflecting a year-over-year change of 30.9% [5]